The largest community of pharma leaders

RAPT Therapeutics Announces the Appointment of Emma Guttman-Yassky, M.D., Ph.D., a Leading Expert in the Field of Inflammatory Skin Diseases, to its Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory diseases, today announced that Emma Guttman-Yassky, M.D., Ph.D., from the Department of Dermatology at the Icahn School of Medicine at Mount Sinai Medical Center in New York, has joined the company’s scientific advisory board. “We are pleased to welcome another thought leader to our scientific advisory ….



Recent Articles